Chicago Capital, LLC Abb Vie Inc. Transaction History

Chicago Capital, LLC

$3.56 Billion
Q3 2024

A detailed history of Chicago Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Chicago Capital, LLC holds 52,696 shares of ABBV stock, worth $9.25 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

52,696

Previous 53,483 1.47%

Holding current value

$9.25 Million

Previous $9.17 Million 13.44%

% of portfolio

0.29%

Previous 0.28%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$163.84 - $199.33 $128,942 - $156,872	-787 Reduced 1.47%	52,696 $10.4 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $53,247 - $62,181	-344 Reduced 0.64%	53,483 $9.17 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $94,613 - $107,803	-592 Reduced 1.09%	53,827 $9.8 Million
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $1.57 Million - $1.77 Million	11,405 Added 26.51%	54,419 $8.43 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $26,718 - $30,930	200 Added 0.47%	43,014 $6.41 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $80,168 - $99,764	-605 Reduced 1.39%	42,814 $5.77 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $11,756 - $14,098	-85 Reduced 0.2%	43,419 $0
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $2,013 - $2,308	15 Added 0.03%	43,504 $5.84 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $192,668 - $244,944	1,400 Added 3.33%	43,489 $6.66 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $182,132 - $225,975	1,380 Added 3.39%	42,089 $6.82 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $65,747 - $83,189	612 Added 1.53%	40,709 $5.51 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $4,256 - $4,831	-40 Reduced 0.1%	40,097 $4.33 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $44,924 - $50,048	427 Added 1.08%	40,137 $4.52 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $44,193 - $48,651	432 Added 1.1%	39,710 $4.3 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $7,324 - $9,888	91 Added 0.23%	39,278 $4.21 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $2,147 - $2,520	25 Added 0.06%	39,187 $3.43 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $657,468 - $879,790	8,961 Added 29.67%	39,162 $3.85 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $22,043 - $26,502	350 Added 1.17%	30,201 $2.29 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $141,255 - $180,557	2,150 Added 7.76%	29,851 $2.17 Million
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $37,027 - $43,579	480 Added 1.76%	27,701 $2.23 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $307,741 - $379,527	3,953 Added 16.99%	27,221 $2.51 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $7,735 - $8,599	87 Added 0.38%	23,268 $2.2 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $237,557 - $281,084	2,646 Added 12.89%	23,181 $2.15 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $1.89 Million - $2.53 Million	20,535 New	20,535 $1.94 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Abb Vie Inc. Transaction History